Corbus Pharmaceuticals Holdings, Inc. (CRBP) is a publicly traded Healthcare sector company. As of May 21, 2026, CRBP trades at $9.93 with a market cap of $184.35M and a P/E ratio of -1.68. CRBP moved +6.56% today. Year to date, CRBP is +24.27%; over the trailing twelve months it is +28.53%. Its 52-week range spans $4.64 to $22.20. Analyst consensus is strong buy with an average price target of $40.78. Rallies surfaces CRBP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own CRBP include Orbimed Advisors. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Corbus Pharmaceuticals Holdings, Inc..
| Metric | Value |
|---|---|
| Price | $9.93 |
| Market Cap | $184.35M |
| P/E Ratio | -1.68 |
| EPS | $-5.74 |
| Dividend Yield | 0.00% |
| 52-Week High | $22.20 |
| 52-Week Low | $4.64 |
| Volume | 1.29K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.25M |
| Net Income | $-84.53M |
| Gross Margin | 0.00% |
10 analysts cover CRBP: 0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $40.78.